CLPTM1L anticorps
-
- Antigène Voir toutes CLPTM1L Anticorps
- CLPTM1L (CLPTM1-Like (CLPTM1L))
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp CLPTM1L est non-conjugé
-
Application
- ELISA, Immunohistochemistry (IHC)
- Purification
- Affinity purification
- Immunogène
- Synthetic peptide of human CLPTM1L
- Isotype
- IgG
- Top Product
- Discover our top product CLPTM1L Anticorps primaire
-
-
- Indications d'application
- IHC 1:50-1:200
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.7 mg/mL
- Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
- Agent conservateur
- Sodium azide
- Conseil sur la manipulation
- Avoid freeze / thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Antigène
- CLPTM1L (CLPTM1-Like (CLPTM1L))
- Autre désignation
- CLPTM1L (CLPTM1L Produits)
- Synonymes
- anticorps CRR9, anticorps C130052I12Rik, anticorps Crr9, anticorps RGD1307896, anticorps C130052I12RIK, anticorps CLPTM1 like, anticorps CLPTM1-like, anticorps cleft lip and palate transmembrane protein 1-like protein, anticorps CLPTM1L, anticorps clptm1l, anticorps LOC100338302, anticorps Clptm1l
- Sujet
- Cleft lip and palate transmembrane protein 1-like protein(CLPTM1-like protein), also known ascisplatin resistance-related protein 9(CRR9p), is aproteinthat in humans is encoded by theCLPTM1Lgene.CRR9p is associated withcisplatin-inducedapoptosis.CLPTM1L, which lies within a cancer susceptibility locus on chromosome 5 (5p15.33), has been found to be commonly over-expressed in lung tumors and to confer resistance to apoptosis caused by genotoxic agents in association with up-regulation of the anti-apoptotic protein, Bcl-xL.
- NCBI Accession
- NP_110409
-